QHR, Gallagher Partnership Yields More Thank $4 Million for QHR Hospit... ( Sixteen QHR ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

QHR, Gallagher Partnership Yields More Thank $4 Million for QHR Hospital Clients

Date:2/19/2009

Sixteen QHR hospital clients received unexpected checks totaling nearly $4.4 million in February. The payments - ranging from $65,000 to more than $750,000 - were paid to QHR hospital clients participating in a unique and innovative partnership between the hospital management company and Gallagher Healthcare Insurance Services. Under the QHR/Gallagher Retro Insurance Program, hospital groups that experience less than projected risk management expenses are eligible for a premium return of up to 50 percent. The checks issued to the QHR group this month reflect premium refunds for 2003 and 2004.

Brentwood, Tenn. (PRWEB) February 19, 2009 -- Sixteen QHR hospital clients received unexpected checks totaling nearly $4.4 million in February.

The payments - ranging from $65,000 to more than $750,000 - were paid to QHR hospital clients participating in a unique and innovative partnership between the hospital management company and Gallagher Healthcare Insurance Services. Under the QHR/Gallagher Retro Insurance Program, hospital groups that experience less than projected risk management expenses are eligible for a premium return of up to 50 percent. The checks issued to the QHR group this month reflect premium refunds for 2003 and 2004.

"Particularly in these challenging times, it's important that hospitals have the financial security and underwriting capacity to participate in a hospital professional liability/general liability insurance plan," said QHR President and CEO James L. Horrar. "This program with Gallagher not only provides access to such a plan, it also allows our hospital clients to benefit when our group meets its risk management goal
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Arthur J. Gallagher & Co. Acquires Life Insurance Strategies
2. Arthur J. Gallagher & Co. Acquires Healthcare Risk Solutions, LLC
3. Arthur J. Gallagher & Co. Acquires Taylor Benefits
4. CG Technology is Now Carlisle & Gallagher Consulting Group
5. Eisai and Bial Announce Partnership Agreement for the European Commercialisation of the Novel Once Daily Anti-Epileptic Zebinix(R)
6. Partnership for Prescription Assistance Prepared to Help Texas Workers Hurt by Recession
7. The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.
8. Sodexo Partnership With The Beryl Companies Breaks Down Barriers to Better Customer Service in Healthcare
9. Press Ganey Unveils Physician Partnership Model
10. Partnership for Prevention: CDC Report Shows Compelling Need for FDA Regulation of Tobacco
11. Nucletron and Advanced Radiation Therapy (ART) Jointly Announce a Global, Strategic Partnership to Offer AccuBoost(R) for Image-Guided Breast Irradiation

Post Your Comments:

Breaking Medicine News(10 mins):Health News:Pitt study suggests craving hinders comprehension without your realizing it 2 Health News:Lilly Announces the First 300-unit Vial of Insulin 2 Health News:Lilly Announces the First 300-unit Vial of Insulin 3 Health News:Lilly Announces the First 300-unit Vial of Insulin 4 Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2 Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3 Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4 Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5 Health News:Pitt study suggests craving hinders comprehension without you realizing it 2 Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 2 Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 3

[0] Pitt study suggests craving hinders comprehension without your realizing it [0] Lilly Announces the First 300-unit Vial of Insulin [0] Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management [0] Pitt study suggests craving hinders comprehension without you realizing it [1] Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange

Julie L. Novak Named Executive Director of Michigan State Medical Society Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 National Health Care Coalition Commends New Congress' Focus on Fighting Chronic Disease in House Stimulus Package Palomar Medical Technologies to Host Fourth Quarter and Year End 2008 Financial Results Conference Call and Webcast on February 5, 2009 Optelec and ShopLowVision.com Bring Life Back Into Focus at ATIA 2009 Orlando Patients' Bath Basins Increase Risk for Hospital-Acquired Infections

Breaking Medicine Technology:Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2 The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2 The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3 The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4 The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5 Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 2 Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program 3 Weight Loss Surgery Breaks Families Obesity Cycle 55987 1 Weight Loss Surgery Breaks Families Obesity Cycle 55987 2 Dr William J Robbins Joins Anpath Group Inc Board of Directors 55984 1 Dr William J Robbins Joins Anpath Group Inc Board of Directors 55984 2 Dr William J Robbins Joins Anpath Group Inc Board of Directors 55984 3 Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting 55979 1 Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting 55979 2 Relapse of Infections is the Most Challenging Aspect of Treating Clostridium Difficile Infections in the Hospital Setting 55979 3

[0] Hill-Rom Announces Appointment of James R. Giertz to Board of Directors [0] The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies [0] Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program

Other Medicine Technology:VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 2 VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 3 VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 4 VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 5 VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 6 New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 2 New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 3 New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 4 New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 5 New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 6

VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma

Medicine Products:

BioPlex® 2200 HSV Non-Typing ASR ImmuLisa Anti-Myeloperoxidase MPO (pANCA)DiffSpin 2

QHR, Gallagher Partnership Yields More Thank $4 Million for QHR Hospit...( Sixteen QHR ...),Health